By Kamal Choudhury Feb 9 (Reuters) - Privately held Iambic said on Monday it has entered a multi-year partnership worth more ...

After sharing word that it would be prioritizing artificial intelligence to aid discovery work, Takeda Pharmaceuticals has inked a multiyear deal to access Iambic Therapeutics' broad suite of& | ...

Digital twins revolutionize drug discovery by integrating AI and biological data, enhancing prediction, trial design, and decision-making in precision medicine.

AI startup Iambic on Monday announced a multi-year technology and discovery collaboration agreement with Takeda Pharmaceutical Company Limited TAK. The Japanese drug maker will use Iambic's AI drug ...

Iambic’s physics-informed NeuralPLexer is intended to enhance protein–ligand modeling, enabling broader exploration of ...

Explore AI in drug discovery and its journey from promise to proof in 2025 with significant achievements and challenges faced.

AI boosts efficiency in early, high-failure R&D, improving success rates and capital efficiency across biotech and pharma.

You can provide a way better UX than this when your app throws errors by providing your own ErrorBoundary or errorElement ...

Researchers from The Ohio State University and the Indian Institute of Technology Madras have developed an artificial intelligence framework to rapidly generate drug-like molecules that are easier to ...

Drug discovery requires two separate steps: checking whether a drug can bind to a harmful molecule or its receptor, and ...

The Precision Medicine market is expanding via advancements in genomic sequencing, AI-driven analytics, and collaborative global genomics programs. Key trends include companion diagnostics in oncology ...

Overview AI is speeding up drug discovery by analyzing large biological and chemical data in a short time.Deep learning and AI systems help design new drug mole ...